# Obesity/Nutrition 

Mackenzie Samson

---

## Background

- BMI = Body Weight (kg) / Height (meters)2

- Underweight = BMI \<18.5

- Normal = BMI 18.5-24.9

- Overweight = BMI 25.0-29.9

- Obesity:

    - Class I 30-34.9

    - Class II 35-39.9

    - Class IIIA 40-44.9

    - Class IIIB 45-49.9

    - Class IIIC 50+

## Management

- Goals: Target initial weight loss of 5-7% body weight, schedule
    frequent follow up to assess progress. Request pts send 48 hr food
    log. Encourage accountability “buddies.” Consider weight loss apps:
    My Fitness Pal, Lose it, Noom

- Dietary options:

    - Calorie restriction \> macronutrient composition (e.g., low fat, low
        carb)

    - Mediterranean: high in unsaturated fats, fruit/veg, legumes, grain,
        moderate dairy & EtOH, less meat. Adherence leads to decreased
        overall mortality and CV mortality; may decrease diabetes incidence
        independent of weight loss

    - Dot phrases below for pictoral representation of cultural diets
        adapted to fit Mediterranean guidelines (Asian, African, Latin
        American)

    - DASH: High in fruits/vegetables, moderate dairy, \< 25% caloric
        intake from fat (decreases SBP/DBP)

- Exercise: \>30 min, 5-7 days per week, ideally a combo of aerobic +
    resistance training.

    - Exercise alone is not sufficient for weight loss

- Medications: If BMI ≥30 or BMI ≥27 with ≥1 comorbidity. Significant
    short term weight loss (\~ 5-15 lbs), but weight is typically gained
    back when stopped. See table below

- Referral to medical weight loss: If BMI ≥ 30 or BMI ≥27 with
    comorbid conditions (fatty liver disease, diabetes mellitus, HTN,
    OSA)

- Referral to surgical weight loss: If BMI ≥40 or BMI ≥35 with
    comorbid conditions

- VA: consider referral to MOVE program (in person/telehealth options)

<table>
<colgroup>
<col style="width: 27%" />
<col style="width: 34%" />
<col style="width: 37%" />
</colgroup>
<thead>
<tr class="header">
<th>Medication</th>
<th>Mechanism</th>
<th>Common Side Effects</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Orlistat (Xenical)</td>
<td>Reduces fat adsorption</td>
<td>Diarrhea, gas, leakage of oily stools, stomach pain</td>
</tr>
<tr class="even">
<td>Phentermine-topiramate (Qsymia)</td>
<td>Phentermine: appetite suppression<br />
<br />
Topiramate (anticonvulsant, migraine txt): ?appetite suppression,
?altered satiety perception</td>
<td>Constipation, dizziness, dry mouth, taste changes, tingling of hands
and feet, insomnia</td>
</tr>
<tr class="odd">
<td>Naltrexone-bupropion (Contrave)</td>
<td>Naltrexone (partial opioid antagonist; used for alcohol dependence):
?altered satiety perception<br />
<br />
Bupropion (antidepressant): ?altered satiety perception</td>
<td>Constipation, diarrhea, dizziness, dry mouth, headache, BP,
tachycardia, insomnia, liver damage, nausea/vomiting</td>
</tr>
<tr class="even">
<td>Liraglutide (Saxenda)</td>
<td>Appetite suppression; quickens satiety<br />
<br />
(Victoza: lower dose formulation, FDA-approved for T2DM)</td>
<td>Nausea, diarrhea, constipation, abdominal pain, headache,
tachycardia</td>
</tr>
<tr class="odd">
<td>Phentermine (Ionamin)</td>
<td>Reduces appetite<br />
Note: FDA-approved only for short-term use—up to 12 weeks</td>
<td>Dry mouth, constipation, insomnia, dizziness, nervousness/
restlessness headache, HTN, tachycardia</td>
</tr>
<tr class="even">
<td>Semaglutide (Ozempic/Rybelsus)</td>
<td>Glucagon-like peptide-1 receptor agonist; reduces appetite</td>
<td>Nausea, vomiting, diarrhea, abdominal pain, constipation</td>
</tr>
</tbody>
</table>

## Additional Information

- EPIC Dot phrases:

    - .NHFOODINSECURITY 

    - .NHFOODASIANDIET 

    - .NHFOODLATINDIET 

    - .NHFOODAFRICANDIET 

    - .NHFOODHEALTHYPLATE 

    - .NHOBESITYYMCA 
